MASTINI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 1.067
EU - Europa 496
AS - Asia 98
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 1.664
Nazione #
US - Stati Uniti d'America 1.056
DE - Germania 203
IT - Italia 131
CN - Cina 62
SE - Svezia 42
GB - Regno Unito 35
BE - Belgio 17
UA - Ucraina 14
VN - Vietnam 13
CA - Canada 11
IE - Irlanda 11
IN - India 11
FR - Francia 10
PL - Polonia 9
TR - Turchia 8
DK - Danimarca 7
NL - Olanda 4
FI - Finlandia 3
ES - Italia 2
GR - Grecia 2
IR - Iran 2
RU - Federazione Russa 2
AT - Austria 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
CL - Cile 1
EU - Europa 1
MK - Macedonia 1
MY - Malesia 1
Totale 1.664
Città #
Ann Arbor 475
Frankfurt am Main 189
Wilmington 115
Fairfield 83
Chandler 78
Milan 59
Woodbridge 59
Ashburn 30
Cambridge 30
Houston 30
Seattle 26
Dearborn 21
Nanjing 18
Brussels 17
Princeton 16
Dublin 11
Altamura 10
Jacksonville 10
Dong Ket 8
Lawrence 8
Lodz 8
Riva del Garda 7
Boardman 6
Kocaeli 6
Edmonton 5
Hangzhou 5
Monza 5
Norwalk 5
Shenyang 5
Hebei 4
Meda 4
Beijing 3
Falls Church 3
Fremont 3
Guangzhou 3
Kunming 3
Ningbo 3
San Diego 3
Shanghai 3
Torino 3
Andover 2
Bradford 2
Casale Monferrato 2
Cernusco sul Naviglio 2
Cinisello Balsamo 2
Jinan 2
Lachine 2
Lana 2
London 2
Maarssen 2
Magenta 2
Marseille 2
Nanchang 2
Quart de Poblet 2
Tianjin 2
Trento 2
Boston 1
Boulder 1
Bytom 1
Cesena 1
Changchun 1
Changsha 1
Chongqing 1
Clearwater 1
Como 1
Dhaka 1
Duncan 1
Genoa 1
Grafing 1
Hefei 1
Helsinki 1
Ilidza 1
Jiaxing 1
Kiev 1
Laurel 1
Lissone 1
Los Angeles 1
Melbourne 1
Montreal 1
Mumbai 1
New Delhi 1
Nürnberg 1
Oakland 1
Ottawa 1
Penang 1
Peschiera 1
Philadelphia 1
Prilep 1
Qingdao 1
Quzhou 1
Redmond 1
Ripalta Cremasca 1
Taizhou 1
Tappahannock 1
Toronto 1
Vezzano sul Crostolo 1
Vienna 1
Vimercate 1
Vittorio Veneto 1
Winnipeg 1
Totale 1.456
Nome #
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer 336
Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma 311
Epitope mapping of spontaneous autoantibodies to anaplastic lymphoma kinase (ALK) in non-small cell lung cancer 245
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency 238
Immune Recognition of ALK Fusion Proteins in Patients with ALK-Rearranged Non-Small Cell Lung Cancer 188
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 164
Efficacy of a cancer vaccine against ALK-rearranged lung tumors 149
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 109
Characterization of the transcriptional landscape of atypical Chronic Myeloid Leukemia at single-cell resolution 36
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience 28
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models 13
Totale 1.817
Categoria #
all - tutte 3.313
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.313


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019140 0 0 1 1 3 17 17 17 8 19 21 36
2019/2020421 37 27 23 48 33 48 61 33 41 34 31 5
2020/2021467 4 21 42 55 44 57 43 46 35 42 34 44
2021/2022202 37 37 24 19 13 14 6 6 6 13 17 10
2022/2023426 25 89 39 42 23 42 29 26 37 25 19 30
2023/202472 34 17 21 0 0 0 0 0 0 0 0 0
Totale 1.817